Project Details
Description
An open-label, non-comparative, multicenter study on the efficacy, safety, and pharmacokinetics of triptorelin pamoate (embonate) 22.5 mg 6-month formulation in patients suffering from central (gonadotropin-dependent) precocious puberty
Status | Finished |
---|---|
Effective start/end date | 6/1/12 → 2/13/14 |
Funding
- SYNEOS HEALTH, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.